XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha

Anne Keriel1, Anne Stary, Alain Sarasin

  • 1Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, BP 163, 67404 Illkirch Cedex, C. U., Strasbourg, France.

Cell
|April 17, 2002
PubMed

Insights

Mutations in the XPD gene, linked to Xeroderma pigmentosum (XP), impair nuclear receptor function beyond DNA repair. This study reveals XPD

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Xeroderma pigmentosum (XP) is a rare genetic disorder caused by mutations in the XPD gene, a component of the transcription/repair factor TFIIH.
  • XP phenotypes suggest roles for XPD beyond DNA repair, but these are not fully understood.

Purpose of the Study:

  • To investigate the non-DNA repair functions of the XPD gene.
  • To explore the impact of XPD mutations on nuclear receptor-mediated transactivation.

Main Methods:

  • Analysis of nuclear receptor transactivation in cells from XP-D patients.
  • Investigating the role of XPD in the phosphorylation of the RARalpha nuclear receptor.
  • Utilizing overexpression of wild-type XPD and a mutated RARalpha (RARalphaS77E) to assess functional restoration.

Main Results:

  • XPD mutations reduce ligand-dependent transactivation of nuclear receptors like RARalpha, ERalpha, and AR.
  • The XPD mutation impairs the cdk7 kinase activity within TFIIH, affecting RARalpha phosphorylation.
  • Restoration of transactivation was observed with wild-type XPD or RARalphaS77E, indicating the importance of proper RARalpha phosphorylation.

Conclusions:

  • The XPD subunit of TFIIH plays a crucial role in regulating nuclear receptor activity through phosphorylation.
  • This phosphorylation, mediated by the cdk7 kinase, is essential for ligand-dependent gene activation.
  • XPD's function extends beyond DNA repair, impacting hormonal gene regulation and potentially contributing to XP phenotypes.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K